Long-term course of humoral and cellular immune responses in outpatients after SARS-CoV-2 infection
Julia Schiffner, Insa Backhaus, Jens Rimmele, Sören Schulz, Till Möhlenkamp, Julia Maria Klemens, Dorinja Zapf, Werner Solbach, Alexander Mischnik
doi: https://doi.org/10.1101/2021.06.24.21259218
Julia Schiffner
1University of Luebeck, Center for Infection and Inflammation Research, Luebeck, Germany; German Center for Infection Research (DZIF), Standort Hamburg-Borstel-Luebeck-Riems
2Health Protection Authority, Luebeck, Germany
Insa Backhaus
3Institute of Medical Sociology, Centre for Health and Society, Medical Faculty and University Hospital, Heinrich-Heine-University, Düsseldorf, Germany
Jens Rimmele
2Health Protection Authority, Luebeck, Germany
Sören Schulz
2Health Protection Authority, Luebeck, Germany
Till Möhlenkamp
2Health Protection Authority, Luebeck, Germany
Julia Maria Klemens
4Institute for Experimental Immunology, affiliated to EUROIMMUN Medizinische Labordiagnostika AG, Luebeck, Germany
Dorinja Zapf
4Institute for Experimental Immunology, affiliated to EUROIMMUN Medizinische Labordiagnostika AG, Luebeck, Germany
Werner Solbach
1University of Luebeck, Center for Infection and Inflammation Research, Luebeck, Germany; German Center for Infection Research (DZIF), Standort Hamburg-Borstel-Luebeck-Riems
2Health Protection Authority, Luebeck, Germany
Alexander Mischnik
2Health Protection Authority, Luebeck, Germany
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
All data are available if you contact the authors.
Posted June 25, 2021.
Long-term course of humoral and cellular immune responses in outpatients after SARS-CoV-2 infection
Julia Schiffner, Insa Backhaus, Jens Rimmele, Sören Schulz, Till Möhlenkamp, Julia Maria Klemens, Dorinja Zapf, Werner Solbach, Alexander Mischnik
medRxiv 2021.06.24.21259218; doi: https://doi.org/10.1101/2021.06.24.21259218
Long-term course of humoral and cellular immune responses in outpatients after SARS-CoV-2 infection
Julia Schiffner, Insa Backhaus, Jens Rimmele, Sören Schulz, Till Möhlenkamp, Julia Maria Klemens, Dorinja Zapf, Werner Solbach, Alexander Mischnik
medRxiv 2021.06.24.21259218; doi: https://doi.org/10.1101/2021.06.24.21259218
Subject Area
Subject Areas
- Addiction Medicine (346)
- Allergy and Immunology (666)
- Anesthesia (181)
- Cardiovascular Medicine (2636)
- Dermatology (223)
- Emergency Medicine (398)
- Epidemiology (12206)
- Forensic Medicine (10)
- Gastroenterology (756)
- Genetic and Genomic Medicine (4081)
- Geriatric Medicine (387)
- Health Economics (679)
- Health Informatics (2639)
- Health Policy (1002)
- Hematology (362)
- HIV/AIDS (849)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (433)
- Neurology (3861)
- Nursing (209)
- Nutrition (575)
- Oncology (2017)
- Ophthalmology (584)
- Orthopedics (240)
- Otolaryngology (304)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (472)
- Pediatrics (1113)
- Primary Care Research (450)
- Public and Global Health (6512)
- Radiology and Imaging (1396)
- Respiratory Medicine (871)
- Rheumatology (403)
- Sports Medicine (342)
- Surgery (442)
- Toxicology (52)
- Transplantation (185)
- Urology (165)